Joseph Klein III, Director at IONIS PHARMACEUTICALS INC (IONS), sold 2,000 shares at $50.45 ($102K) on 2018-03-15, disclosed to the SEC on 2018-03-16.
Open-market sale of $102k IONS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.45 | 900 | $45K | 44.4% |
| 2 | $51.59 | 900 | $46K | 45.4% |
| 3 | $52.11 | 200 | $10K | 10.2% |
| Total | $51.13 avg | 2,000 | $102K | 100% |
| Filing → |
| IONS | SELL | 2026-04-02 | $1.7M | — | Filing → |
| IONS | SELL | 2026-03-05 | $3.4M | — | Filing → |
| IONS | SELL | 2025-11-28 | $320K | — | Filing → |